PlainDoctor

2026 NPPES data Transplant Hepatology Physician NPI 1043536717 M.D.
Verify on CMS →

Matthew Stotts, M.D.

Transplant Hepatology Physician in Denver, Colorado.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 151 in Transplant Hepatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
217
Medicare Part D claims · 40 beneficiaries · Transplant Hepatology Physician avg: 553
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.4/100
▼ 4 pts below national avg 83.5 · Above neutral
Industry payments
$7.5K
11 payments · CMS Open Payments (Sunshine Act)
Verify NPI on CMS Methodology
Compiled from official public sources by the editorial process.

What the federal data shows

Matthew Stotts, M.D. reported a CMS MIPS final score of 79.4/100 - below the 83.5 national average - and filed 217 Medicare Part D claims in 2024.

79.4/100
MIPS score · -4 vs avg
217
Part D claims, 2024
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Matthew Stotts, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1043536717), first enumerated 04/20/2010.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 217 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 79.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $7.5K in reported industry payments (11 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1043536717 · Transplant Hepatology Physician

NPI-10 · ENUM-MID · TAX-TRACE · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1043536717
  • ENUM-MID 2010
  • TAX-TRACE 151
  • MIPS-BELOW 79.4/100
  • RX-LIGHT 217
  • BOOK-THIN 3 in Colorado
  • PHOTO-FINISH Naemat Sandhu · ±0.1

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Matthew Stotts, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

79 ≥ 26th percentile 26% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). This entry sits in this band. 80–90: 129,887 measured providers (29%). Above this entry. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Matthew Stotts, M.D. sits

This provider among transplant hepatology physician peers

Across the 56 transplant hepatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Stotts, M.D. writes more Part D claims than 32% of them and scores higher on MIPS quality than 25% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100022.144.166.288.2Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 76 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 16Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 91 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 36Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 69 · MIPS quality, percentile: 44Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 9Point, Part D claim volume, percentile in specialty: 9 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 11 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 24 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 9Point, Part D claim volume, percentile in specialty: 16 · MIPS quality, percentile: 56Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 51Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 29Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 84 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 31 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 31Point, Part D claim volume, percentile in specialty: 64 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 89 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 44 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 51 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 4 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 29 · MIPS quality, percentile: 4Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 96 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 69Point, Part D claim volume, percentile in specialty: 36 · MIPS quality, percentile: 69Point, Part D claim volume, percentile in specialty: 71 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 42Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 84Point, Part D claim volume, percentile in specialty: 56 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 49 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 24Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 56 · MIPS quality, percentile: 64Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 16Matthew Stotts, M.D., Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 25
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one transplant hepatology physician peer from a representative sample of 55; the gold marker is Matthew Stotts, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

✓
Board certification likely (heuristic, not verified)

Matthew Stotts, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Matthew Stotts, M.D.?

Near national average

NPI registry status

Active

Issued 04/20/2010

NPI 1043536717

Primary specialty

Transplant Hepatology Physician

Rare

151 US NPIs in this specialty

Medicare Part D claims

217 61% vs specialty avg

2024 prescription claims

Specialty avg: 553

MIPS final score

79.4/100 4.1 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in Colorado

How Transplant Hepatology Physician compares to other specialties among Colorado providers

Colorado providers
Behavior Technician8.2%Mental Health Counselor6.1%Clinical Social Worker4.3%Physical Therapist4.2%Professional Counselor3.7%Registered Nurse3.6%Transplant Hepatology Physic…0%
Largest specialties in Colorado (% of in-state providers)

Medicare quality performance, MIPS

Matthew Stotts, M.D.'s 2023 MIPS final score plotted against the Transplant Hepatology Physician national average

Near national average
MIPS Final Score
79.4/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%79.4%
MIPS final score (Transplant Hepatology Physician) - 79.4/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

2535 S DOWNING ST STE 380
Denver, CO 80210
(303) 778-5797

Provider Details

NPI 1043536717
Specialty Transplant Hepatology Physician
Credentials M.D.
Gender Male
NPI Issued 04/20/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.3949
Final Score
Measured-score avg: 83.5
73.6607
Quality
57.6556
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Matthew Stotts, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Portercare Adventist Health System
Windsor, CO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Stotts, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$7.5K

Largest payer

Ultragenyx Pharmaceutical Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Matthew Stotts, M.D. - brand share 12.0%
Transplant Hepatology Physician average

12% brand-name claims vs 88% generic, on 217 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

217
Total Claims
$203K
Total Drug Cost
40
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
280.167
Total Day Supply
8,160
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$188K
Generic Drug Cost
$15K
Antibiotic Claims
25

Patient Demographics

Average Patient Age
67.6 years
Avg HCC Risk Score
2.62
Gender Split
30% female / 70% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Matthew Stotts, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Furosemide
 37
Spironolactone
 31
Ursodiol
 21
Midodrine Hcl
 20
Xifaxan
Rifaximin
18
Lactulose
 12
Tacrolimus
 11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

More Transplant Hepatology Physician in CO → All providers in Colorado → Compare specialties →

Transplant Hepatology Physician Overview

How Matthew Stotts, M.D. fits within the Transplant Hepatology Physician landscape nationally.

151
Transplant Hepatology Physician Providers in US
36
States with Transplant Hepatology Physician
553
Avg Claims per Provider

Matthew Stotts, M.D.'s 217 claims are below the specialty average of 553.

Nationwide Transplant Hepatology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Stotts, both outside Colorado so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (79.4 here).

Naemat Sandhu 79.5 OH Catherine Lucero 79.1 NY Francisco Durazo 80.5 WI Ayman Koteish 78 FL

Same NPPES enumeration year (2010)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Therese Bittermann Philadelphia, PA Rex Cheng Seattle, WA

Nearby Transplant Hepatology Physician Providers in Colorado

Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as Stotts.

One of 3 Transplant Hepatology Physician providers enrolled in Colorado, 2 are shown here.

Dr. Nathan Susnow
MD
Lafayette, CO
Dr. Amanda Wieland
MD
Aurora, CO

Compare Transplant Hepatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Matthew Stotts, M.D.'s specialty? ▼
Matthew Stotts, M.D. specializes in Transplant Hepatology Physician and practices in Denver, Colorado. Credentials: M.D..
How much does Matthew Stotts, M.D. prescribe under Medicare Part D? ▼
In 2024, Matthew Stotts, M.D. wrote 217 Medicare Part D claims totaling $203K in drug costs for 40 beneficiaries.
What is Matthew Stotts, M.D.'s Medicare quality score? ▼
Matthew Stotts, M.D. has a CMS MIPS Final Score of 79.4/100 (Quality: 73.7, Cost: 57.7). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Matthew Stotts, M.D. located? ▼
Matthew Stotts, M.D. is located at 2535 S DOWNING ST STE 380, Denver, CO, 80210. Phone: (303) 778-5797.
What is Matthew Stotts, M.D.'s NPI number? ▼
Matthew Stotts, M.D.'s National Provider Identifier (NPI) is 1043536717, issued on 04/20/2010.
Does Matthew Stotts, M.D. prescribe more brand-name or generic drugs? ▼
Matthew Stotts, M.D.'s prescribing is 12% brand-name and 88% generic drugs by claim count, with $188K in brand drug costs.
How many Transplant Hepatology Physician providers are there in the US? ▼
There are 151 Transplant Hepatology Physician providers across 36 states in the US. The average Transplant Hepatology Physician provider writes 553 Medicare Part D claims per year.
What drugs does Matthew Stotts, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Stotts, M.D.'s most frequently prescribed drugs include Furosemide, Spironolactone, Ursodiol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Stotts, M.D. accept Medicare? ▼
Matthew Stotts, M.D. appears in CMS Medicare data with 217 Part D claims and 40 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Stotts, M.D.'s credentials? ▼
Matthew Stotts, M.D.'s NPI is 1043536717 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.